… Author links open overlay panel Giovanni Novi a , Malgorzata Mikulska b c , Federica Briano
b c , Federica Toscanini c , Francesco Tazza c d , … Francesco Tazza reports no disclosures …

… F. Bovis reports no disclosures relevant to the manuscript. S. … F. Tazza reports no disclosures
relevant to the manuscript. P. Gazzola reports no disclosures relevant to the manuscript. …

Data regarding effectiveness and safety of ocrelizumab in the post-marking setting are
lacking. The aim of our study was to provide effectiveness and safety data of ocrelizumab …

Guillain–Barré syndrome (GBS) is an autoimmune neurological disorder often preceded by
viral illnesses or, more rarely, vaccinations. We report on a unique combination of …

Soma and neurite density image (SANDI) is an advanced diffusion magnetic resonance imaging
biophysical signal model devised to probe in vivo microstructural information in the gray …

During SARS-CoV-2 pandemic, we adopted a personalized delayed protocol for ocrelizumab
infusions in Relapsing Remitting Multiple Sclerosis (RRMS) patients according to the …

The central vein sign (CVS) has been proposed as a biomarker of multiple sclerosis (MS). In
adult-onset MS (AOMS), 40%-threshold of CVS positive (+) lesions demonstrated high …

Introduction The subventricular zone (SVZ) represents one of the main adult brain
neurogenesis niche. In-vivo imaging of SVZ is very challenging and little is known about MRI …

Background: Although apathy has been associated with fronto-striatal dysfunction in several
neurological disorders, its clinical and magnetic resonance imaging (MRI) correlates have …

Introduction The Central Vein Sign (CVS) has been suggested as a potential biomarker to
improve diagnostic specificity in multiple sclerosis (MS). Nevertheless, the impact of …